ID   CNTN1_HUMAN             Reviewed;        1018 AA.
AC   Q12860; A8K0H9; A8K0Y3; Q12861; Q14030; Q7M4P0; Q8N466;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 201.
DE   RecName: Full=Contactin-1;
DE   AltName: Full=Glycoprotein gp135;
DE   AltName: Full=Neural cell surface protein F3;
DE   Flags: Precursor;
GN   Name=CNTN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Neuroblastoma;
RX   PubMed=8164510; DOI=10.1016/0169-328x(94)90372-7;
RA   Reid R.A., Bronson D.D., Young K.M., Hemperly J.J.;
RT   "Identification and characterization of the human cell adhesion molecule
RT   contactin.";
RL   Brain Res. Mol. Brain Res. 21:1-8(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=7959734; DOI=10.1006/geno.1994.1316;
RA   Berglund E.O., Ranscht B.;
RT   "Molecular cloning and in situ localization of the human contactin gene
RT   (CNTN1) on chromosome 12q11-q12.";
RL   Genomics 21:571-582(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Amygdala, and Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PROTEIN SEQUENCE OF 21-40 AND 679-693 (ISOFORM 1), SUBUNIT, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain cortex;
RX   PubMed=2026173; DOI=10.1111/j.1432-1033.1991.tb15943.x;
RA   Berglund E., Stigbrand T., Carlsson S.R.;
RT   "Isolation and characterization of a membrane glycoprotein from human brain
RT   with sequence similarities to cell adhesion proteins from chicken and
RT   mouse.";
RL   Eur. J. Biochem. 197:549-554(1991).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-494.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [7]
RP   GLYCOSYLATION AT ASN-494.
RX   PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B.,
RA   Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L.,
RA   Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core fucosylated
RT   glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [8]
RP   INTERACTION WITH PTPRZ1.
RX   PubMed=20133774; DOI=10.1073/pnas.0911235107;
RA   Bouyain S., Watkins D.J.;
RT   "The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members
RT   of the contactin family of neural recognition molecules.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:2443-2448(2010).
RN   [9]
RP   STRUCTURE BY NMR OF 791-903.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structures of the FN3 domain of human contactin 1.";
RL   Submitted (AUG-2007) to the PDB data bank.
RN   [10]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-794.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [11]
RP   INVOLVEMENT IN MYPCN.
RX   PubMed=19026398; DOI=10.1016/j.ajhg.2008.10.022;
RA   Compton A.G., Albrecht D.E., Seto J.T., Cooper S.T., Ilkovski B.,
RA   Jones K.J., Challis D., Mowat D., Ranscht B., Bahlo M., Froehner S.C.,
RA   North K.N.;
RT   "Mutations in contactin-1, a neural adhesion and neuromuscular junction
RT   protein, cause a familial form of lethal congenital myopathy.";
RL   Am. J. Hum. Genet. 83:714-724(2008).
CC   -!- FUNCTION: Contactins mediate cell surface interactions during nervous
CC       system development. Involved in the formation of paranodal axo-glial
CC       junctions in myelinated peripheral nerves and in the signaling between
CC       axons and myelinating glial cells via its association with CNTNAP1.
CC       Participates in oligodendrocytes generation by acting as a ligand of
CC       NOTCH1. Its association with NOTCH1 promotes NOTCH1 activation through
CC       the released notch intracellular domain (NICD) and subsequent
CC       translocation to the nucleus. Interaction with TNR induces a repulsion
CC       of neurons and an inhibition of neurite outgrowth (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Monomer (PubMed:2026173). Interacts with CNTNAP1 in cis form
CC       (By similarity). Binds to the carbonic-anhydrase like domain of PTPRZ1
CC       (PubMed:20133774). Interacts with NOTCH1 and TNR. Detected in a complex
CC       with NRCAM and PTPRB (By similarity). Interacts with TASOR (By
CC       similarity). {ECO:0000250|UniProtKB:P12960,
CC       ECO:0000250|UniProtKB:Q63198, ECO:0000269|PubMed:20133774,
CC       ECO:0000269|PubMed:2026173}.
CC   -!- INTERACTION:
CC       Q12860; Q9UHC6: CNTNAP2; NbExp=5; IntAct=EBI-5564336, EBI-310892;
CC       Q12860; P23471: PTPRZ1; NbExp=3; IntAct=EBI-5564336, EBI-2263175;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane; Lipid-anchor, GPI-
CC       anchor; Extracellular side.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane; Lipid-anchor, GPI-
CC       anchor; Extracellular side.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q12860-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q12860-2; Sequence=VSP_002500;
CC       Name=3;
CC         IsoId=Q12860-3; Sequence=VSP_011959, VSP_011960;
CC   -!- TISSUE SPECIFICITY: Strongly expressed in brain and in neuroblastoma
CC       and retinoblastoma cell lines. Lower levels of expression in lung,
CC       pancreas, kidney and skeletal muscle. {ECO:0000269|PubMed:2026173,
CC       ECO:0000269|PubMed:8164510}.
CC   -!- DISEASE: Myopathy, congenital, Compton-North (MYPCN) [MIM:612540]: A
CC       lethal, autosomal recessive, congenital myopathy characterized by fetal
CC       akinesia, neonatal hypotonia, severe muscle weakness, loss of beta2-
CC       syntrophin and alpha-dystrobrevin from the muscle sarcolemma and
CC       disruption of sarcomeres with disorganization of the Z band.
CC       {ECO:0000269|PubMed:19026398}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. Contactin
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z21488; CAA79696.1; -; mRNA.
DR   EMBL; U07819; AAA67920.1; -; mRNA.
DR   EMBL; U07820; AAA67921.1; -; mRNA.
DR   EMBL; AK289544; BAF82233.1; -; mRNA.
DR   EMBL; AK289698; BAF82387.1; -; mRNA.
DR   EMBL; BC036569; AAH36569.1; -; mRNA.
DR   CCDS; CCDS58225.1; -. [Q12860-3]
DR   CCDS; CCDS8737.1; -. [Q12860-1]
DR   CCDS; CCDS8738.1; -. [Q12860-2]
DR   PIR; A54744; A54744.
DR   PIR; S15394; S15394.
DR   RefSeq; NP_001242992.1; NM_001256063.1. [Q12860-3]
DR   RefSeq; NP_001242993.1; NM_001256064.1. [Q12860-3]
DR   RefSeq; NP_001834.2; NM_001843.3. [Q12860-1]
DR   RefSeq; NP_778203.1; NM_175038.2. [Q12860-2]
DR   RefSeq; XP_005268708.1; XM_005268651.2. [Q12860-1]
DR   RefSeq; XP_006719304.1; XM_006719241.2. [Q12860-1]
DR   RefSeq; XP_011536228.1; XM_011537926.2. [Q12860-1]
DR   RefSeq; XP_011536229.1; XM_011537927.2. [Q12860-1]
DR   RefSeq; XP_016874314.1; XM_017018825.1.
DR   RefSeq; XP_016874315.1; XM_017018826.1. [Q12860-3]
DR   RefSeq; XP_016874316.1; XM_017018827.1. [Q12860-3]
DR   PDB; 2EE2; NMR; -; A=798-903.
DR   PDB; 3S97; X-ray; 2.30 A; C/D=133-329.
DR   PDBsum; 2EE2; -.
DR   PDBsum; 3S97; -.
DR   AlphaFoldDB; Q12860; -.
DR   SMR; Q12860; -.
DR   BioGRID; 107672; 40.
DR   DIP; DIP-59714N; -.
DR   IntAct; Q12860; 28.
DR   MINT; Q12860; -.
DR   STRING; 9606.ENSP00000447006; -.
DR   GlyConnect; 1930; 6 N-Linked glycans (6 sites).
DR   GlyGen; Q12860; 11 sites, 6 N-linked glycans (6 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; Q12860; -.
DR   PhosphoSitePlus; Q12860; -.
DR   SwissPalm; Q12860; -.
DR   BioMuta; CNTN1; -.
DR   DMDM; 2497301; -.
DR   EPD; Q12860; -.
DR   jPOST; Q12860; -.
DR   MassIVE; Q12860; -.
DR   MaxQB; Q12860; -.
DR   PaxDb; Q12860; -.
DR   PeptideAtlas; Q12860; -.
DR   PRIDE; Q12860; -.
DR   ProteomicsDB; 58988; -. [Q12860-1]
DR   ProteomicsDB; 58989; -. [Q12860-2]
DR   ProteomicsDB; 58990; -. [Q12860-3]
DR   TopDownProteomics; Q12860-3; -. [Q12860-3]
DR   ABCD; Q12860; 1 sequenced antibody.
DR   Antibodypedia; 25021; 344 antibodies from 40 providers.
DR   DNASU; 1272; -.
DR   Ensembl; ENST00000347616.5; ENSP00000325660.3; ENSG00000018236.15. [Q12860-1]
DR   Ensembl; ENST00000348761.2; ENSP00000261160.3; ENSG00000018236.15. [Q12860-2]
DR   Ensembl; ENST00000547702.5; ENSP00000448004.1; ENSG00000018236.15. [Q12860-3]
DR   Ensembl; ENST00000547849.5; ENSP00000448653.1; ENSG00000018236.15. [Q12860-3]
DR   Ensembl; ENST00000551295.7; ENSP00000447006.1; ENSG00000018236.15. [Q12860-1]
DR   GeneID; 1272; -.
DR   KEGG; hsa:1272; -.
DR   MANE-Select; ENST00000551295.7; ENSP00000447006.1; NM_001843.4; NP_001834.2.
DR   UCSC; uc001rmm.3; human. [Q12860-1]
DR   CTD; 1272; -.
DR   DisGeNET; 1272; -.
DR   GeneCards; CNTN1; -.
DR   HGNC; HGNC:2171; CNTN1.
DR   HPA; ENSG00000018236; Tissue enhanced (brain).
DR   MalaCards; CNTN1; -.
DR   MIM; 600016; gene.
DR   MIM; 612540; phenotype.
DR   neXtProt; NX_Q12860; -.
DR   OpenTargets; ENSG00000018236; -.
DR   Orphanet; 210163; Congenital lethal myopathy, Compton-North type.
DR   PharmGKB; PA26685; -.
DR   VEuPathDB; HostDB:ENSG00000018236; -.
DR   eggNOG; KOG3513; Eukaryota.
DR   GeneTree; ENSGT00940000155915; -.
DR   HOGENOM; CLU_005756_0_1_1; -.
DR   InParanoid; Q12860; -.
DR   OMA; PNHEVRM; -.
DR   PhylomeDB; Q12860; -.
DR   TreeFam; TF351103; -.
DR   PathwayCommons; Q12860; -.
DR   Reactome; R-HSA-2122948; Activated NOTCH1 Transmits Signal to the Nucleus.
DR   Reactome; R-HSA-2979096; NOTCH2 Activation and Transmission of Signal to the Nucleus.
DR   Reactome; R-HSA-373760; L1CAM interactions.
DR   Reactome; R-HSA-447043; Neurofascin interactions.
DR   SignaLink; Q12860; -.
DR   BioGRID-ORCS; 1272; 40 hits in 1072 CRISPR screens.
DR   ChiTaRS; CNTN1; human.
DR   EvolutionaryTrace; Q12860; -.
DR   GeneWiki; CNTN1; -.
DR   GenomeRNAi; 1272; -.
DR   Pharos; Q12860; Tbio.
DR   PRO; PR:Q12860; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q12860; protein.
DR   Bgee; ENSG00000018236; Expressed in cortical plate and 163 other tissues.
DR   ExpressionAtlas; Q12860; baseline and differential.
DR   Genevisible; Q12860; HS.
DR   GO; GO:0099025; C:anchored component of postsynaptic membrane; IEA:Ensembl.
DR   GO; GO:0099026; C:anchored component of presynaptic membrane; IEA:Ensembl.
DR   GO; GO:0030424; C:axon; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0045121; C:membrane raft; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0098632; F:cell-cell adhesion mediator activity; IBA:GO_Central.
DR   GO; GO:0007411; P:axon guidance; IBA:GO_Central.
DR   GO; GO:0007420; P:brain development; IBA:GO_Central.
DR   GO; GO:0007155; P:cell adhesion; NAS:ProtInc.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0032289; P:central nervous system myelin formation; IEA:Ensembl.
DR   GO; GO:0021549; P:cerebellum development; IEA:Ensembl.
DR   GO; GO:0010467; P:gene expression; IEA:Ensembl.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0007219; P:Notch signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IEA:Ensembl.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; IEA:Ensembl.
DR   GO; GO:0010765; P:positive regulation of sodium ion transport; IEA:Ensembl.
DR   CDD; cd00063; FN3; 4.
DR   Gene3D; 2.60.40.10; -; 10.
DR   InterPro; IPR036992; Contactin-1.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   PANTHER; PTHR44170:SF10; PTHR44170:SF10; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 2.
DR   SMART; SM00060; FN3; 4.
DR   SMART; SM00409; IG; 6.
DR   SMART; SM00408; IGc2; 5.
DR   SUPFAM; SSF48726; SSF48726; 6.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS50835; IG_LIKE; 6.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; GPI-anchor;
KW   Immunoglobulin domain; Lipoprotein; Membrane; Notch signaling pathway;
KW   Reference proteome; Repeat; Signal.
FT   SIGNAL          1..20
FT   CHAIN           21..?993
FT                   /note="Contactin-1"
FT                   /id="PRO_0000014685"
FT   PROPEP          ?994..1018
FT                   /note="Removed in mature form"
FT                   /id="PRO_0000014686"
FT   DOMAIN          41..131
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          137..223
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          241..326
FT                   /note="Ig-like C2-type 3"
FT   DOMAIN          331..407
FT                   /note="Ig-like C2-type 4"
FT   DOMAIN          413..500
FT                   /note="Ig-like C2-type 5"
FT   DOMAIN          504..601
FT                   /note="Ig-like C2-type 6"
FT   DOMAIN          606..704
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          709..806
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          811..906
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          907..1000
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          693..717
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   LIPID           993
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        208
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        258
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        338
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        457
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        473
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        494
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19139490"
FT   CARBOHYD        521
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        591
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        933
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        65..114
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        158..211
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        263..310
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        352..391
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        436..484
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        526..583
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         21..31
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7959734"
FT                   /id="VSP_002500"
FT   VAR_SEQ         603..627
FT                   /note="PPGPPGGLRIEDIRATSVALTWSRG -> KNRKGGEKNMVDSFLPVCASLPP
FT                   TW (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011959"
FT   VAR_SEQ         628..1018
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011960"
FT   VARIANT         794
FT                   /note="P -> H (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035506"
FT   VARIANT         798
FT                   /note="V -> L (in dbSNP:rs1056020)"
FT                   /id="VAR_011722"
FT   VARIANT         824
FT                   /note="E -> G (in dbSNP:rs11553341)"
FT                   /id="VAR_049866"
FT   CONFLICT        682
FT                   /note="V -> I (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        687
FT                   /note="L -> P (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        689
FT                   /note="R -> I (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        692
FT                   /note="P -> F (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          146..149
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          154..156
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          162..166
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          169..176
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          184..189
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   TURN            191..193
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          196..200
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   HELIX           203..205
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          207..215
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   HELIX           216..218
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          220..223
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          227..232
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          240..247
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          251..254
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          259..269
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          272..277
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          287..289
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   TURN            290..293
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          294..297
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          306..314
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          317..328
FT                   /evidence="ECO:0007829|PDB:3S97"
FT   STRAND          816..821
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   STRAND          824..828
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   STRAND          839..849
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   HELIX           851..853
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   STRAND          855..860
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   STRAND          864..868
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   STRAND          876..884
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   STRAND          886..888
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   STRAND          896..899
FT                   /evidence="ECO:0007829|PDB:2EE2"
FT   CONFLICT        Q12860-3:610
FT                   /note="K -> I (in Ref. 3; BAF82233)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1018 AA;  113320 MW;  4B8FDC5BFD434ED5 CRC64;
     MKMWLLVSHL VIISITTCLA EFTWYRRYGH GVSEEDKGFG PIFEEQPINT IYPEESLEGK
     VSLNCRARAS PFPVYKWRMN NGDVDLTSDR YSMVGGNLVI NNPDKQKDAG IYYCLASNNY
     GMVRSTEATL SFGYLDPFPP EERPEVRVKE GKGMVLLCDP PYHFPDDLSY RWLLNEFPVF
     ITMDKRRFVS QTNGNLYIAN VEASDKGNYS CFVSSPSITK SVFSKFIPLI PIPERTTKPY
     PADIVVQFKD VYALMGQNVT LECFALGNPV PDIRWRKVLE PMPSTAEIST SGAVLKIFNI
     QLEDEGIYEC EAENIRGKDK HQARIYVQAF PEWVEHINDT EVDIGSDLYW PCVATGKPIP
     TIRWLKNGYA YHKGELRLYD VTFENAGMYQ CIAENTYGAI YANAELKILA LAPTFEMNPM
     KKKILAAKGG RVIIECKPKA APKPKFSWSK GTEWLVNSSR ILIWEDGSLE INNITRNDGG
     IYTCFAENNR GKANSTGTLV ITDPTRIILA PINADITVGE NATMQCAASF DPALDLTFVW
     SFNGYVIDFN KENIHYQRNF MLDSNGELLI RNAQLKHAGR YTCTAQTIVD NSSASADLVV
     RGPPGPPGGL RIEDIRATSV ALTWSRGSDN HSPISKYTIQ TKTILSDDWK DAKTDPPIIE
     GNMEAARAVD LIPWMEYEFR VVATNTLGRG EPSIPSNRIK TDGAAPNVAP SDVGGGGGRN
     RELTITWAPL SREYHYGNNF GYIVAFKPFD GEEWKKVTVT NPDTGRYVHK DETMSPSTAF
     QVKVKAFNNK GDGPYSLVAV INSAQDAPSE APTEVGVKVL SSSEISVHWE HVLEKIVESY
     QIRYWAAHDK EEAANRVQVT SQEYSARLEN LLPDTQYFIE VGACNSAGCG PPSDMIEAFT
     KKAPPSQPPR IISSVRSGSR YIITWDHVVA LSNESTVTGY KVLYRPDGQH DGKLYSTHKH
     SIEVPIPRDG EYVVEVRAHS DGGDGVVSQV KISGAPTLSP SLLGLLLPAF GILVYLEF
//
